374 related articles for article (PubMed ID: 27561771)
1. Aspirin and Cancer.
Patrignani P; Patrono C
J Am Coll Cardiol; 2016 Aug; 68(9):967-76. PubMed ID: 27561771
[TBL] [Abstract][Full Text] [Related]
2. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement.
Bibbins-Domingo K;
Ann Intern Med; 2016 Jun; 164(12):836-45. PubMed ID: 27064677
[TBL] [Abstract][Full Text] [Related]
3. Aspirin for Primary Prevention.
Richman IB; Owens DK
Med Clin North Am; 2017 Jul; 101(4):713-724. PubMed ID: 28577622
[TBL] [Abstract][Full Text] [Related]
4. Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force.
Dehmer SP; Maciosek MV; Flottemesch TJ; LaFrance AB; Whitlock EP
Ann Intern Med; 2016 Jun; 164(12):777-86. PubMed ID: 27064573
[TBL] [Abstract][Full Text] [Related]
5. Which Aspirin Dose and Preparation Is Best for the Long-Term Prevention of Cardiovascular Disease and Cancer? Evidence From a Systematic Review and Network Meta-Analysis.
Lotrionte M; Biasucci LM; Peruzzi M; Frati G; Giordano A; Biondi-Zoccai G
Prog Cardiovasc Dis; 2016; 58(5):495-504. PubMed ID: 26851562
[TBL] [Abstract][Full Text] [Related]
6. US panel narrows recommendations for low dose aspirin for cardiovascular disease prevention.
McCarthy M
BMJ; 2015 Sep; 351():h4991. PubMed ID: 26392600
[No Abstract] [Full Text] [Related]
7. Aspirin for primary prevention: USPSTF recommendations for CVD and colorectal cancer.
Smith DK; Demetriou T; Weber C
J Fam Pract; 2019 Apr; 68(3):146-151. PubMed ID: 31039213
[TBL] [Abstract][Full Text] [Related]
8. Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.
; Davidson KW; Barry MJ; Mangione CM; Cabana M; Chelmow D; Coker TR; Davis EM; Donahue KE; Jaén CR; Krist AH; Kubik M; Li L; Ogedegbe G; Pbert L; Ruiz JM; Stevermer J; Tseng CW; Wong JB
JAMA; 2022 Apr; 327(16):1577-1584. PubMed ID: 35471505
[TBL] [Abstract][Full Text] [Related]
9. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer.
McNellis RJ; Beswick-Escanlar V
Am Fam Physician; 2016 Oct; 94(8):661-662. PubMed ID: 27929225
[No Abstract] [Full Text] [Related]
10. A review and study of aspirin utilization for the primary prevention of cardiovascular events in a psychiatric population.
Victor K; Skelly M; Mulcahy K; Demler TL; Trigoboff E
Int Clin Psychopharmacol; 2018 Sep; 33(5):274-281. PubMed ID: 29939889
[TBL] [Abstract][Full Text] [Related]
11. Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease: Advances in Diagnosis and Treatment.
Mora S; Manson JE
JAMA Intern Med; 2016 Aug; 176(8):1195-204. PubMed ID: 27322595
[TBL] [Abstract][Full Text] [Related]
12. Aspirin for primary prevention: yes or no?
Selak V; Elley CR; Wells S; Rodgers A; Sharpe N
J Prim Health Care; 2010 Jun; 2(2):92-9. PubMed ID: 20690297
[TBL] [Abstract][Full Text] [Related]
13. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: Recommendation Statement.
Am Fam Physician; 2016 Oct; 94(8):Online. PubMed ID: 27929224
[No Abstract] [Full Text] [Related]
14. Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women.
van Kruijsdijk RC; Visseren FL; Ridker PM; Dorresteijn JA; Buring JE; van der Graaf Y; Cook NR
Heart; 2015 Mar; 101(5):369-76. PubMed ID: 25475110
[TBL] [Abstract][Full Text] [Related]
15. Balancing the risk and benefits of low-dose aspirin in clinical practice.
Casado-Arroyo R; Gargallo C; Lanas Arbeloa A
Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):173-84. PubMed ID: 22542155
[TBL] [Abstract][Full Text] [Related]
16. Low-dose acetylsalicylic acid for primary prevention of cardiovascular disease: Do not misinterpret the recommendations.
Truong C
Can Fam Physician; 2015 Nov; 61(11):971-5. PubMed ID: 26564657
[No Abstract] [Full Text] [Related]
17. Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force.
Chubak J; Whitlock EP; Williams SB; Kamineni A; Burda BU; Buist DS; Anderson ML
Ann Intern Med; 2016 Jun; 164(12):814-25. PubMed ID: 27064482
[TBL] [Abstract][Full Text] [Related]
18. Recent Evidence Examining Efficacy and Safety of Aspirin for Primary Cardiovascular Disease Prevention.
Carson E; Hemenway AN
Ann Pharmacother; 2019 Jul; 53(7):738-745. PubMed ID: 30654618
[TBL] [Abstract][Full Text] [Related]
19. Which patients should receive aspirin for primary prevention of cardiovascular disease? An economic evaluation.
Annemans L; Lamotte M; Kubin M; Evers T; Verheugt FW
Int J Clin Pract; 2006 Sep; 60(9):1129-37. PubMed ID: 16939558
[TBL] [Abstract][Full Text] [Related]
20. Decision-making in an era of cancer prevention via aspirin: New Zealand needs updated guidelines and risk calculators.
Wilson N; Selak V; Blakely T; Leung W; Clarke P; Jackson R; Knight J; Nghiem N
N Z Med J; 2016 Mar; 129(1431):85-92. PubMed ID: 27005878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
